224 related articles for article (PubMed ID: 17458823)
1. [The cardiorenal syndrome: an emerging renal disease].
Fabbian F
G Ital Nefrol; 2007; 24(2):108. PubMed ID: 17458823
[No Abstract] [Full Text] [Related]
2. [The cardiorenal syndrome and erythropoietin].
Kes P; Basić-Jukić N; Jurić I; Basić-Kes V
Acta Med Croatica; 2008; 62 Suppl 1():21-31. PubMed ID: 18578329
[TBL] [Abstract][Full Text] [Related]
3. Cardiorenal syndrome.
Mahapatra HS; Lalmalsawma R; Singh NP; Kumar M; Tiwari SC
Iran J Kidney Dis; 2009 Apr; 3(2):61-70. PubMed ID: 19395780
[TBL] [Abstract][Full Text] [Related]
4. Hyperkalemia risk and treatment of heart failure.
Segura J; Ruilope LM
Heart Fail Clin; 2008 Oct; 4(4):455-64. PubMed ID: 18760757
[TBL] [Abstract][Full Text] [Related]
5. Changes in kidney function following heart failure treatment: focus on renin-angiotensin system blockade.
Blankstein R; Bakris GL
Heart Fail Clin; 2008 Oct; 4(4):425-38. PubMed ID: 18760754
[TBL] [Abstract][Full Text] [Related]
6. The severe cardiorenal syndrome: 'Guyton revisited'.
Bongartz LG; Cramer MJ; Doevendans PA; Joles JA; Braam B
Eur Heart J; 2005 Jan; 26(1):11-7. PubMed ID: 15615794
[TBL] [Abstract][Full Text] [Related]
7. [Cardiorenal syndrome, current understanding].
Ronco F; Ronco C
Recenti Prog Med; 2009 Apr; 100(4):202-13. PubMed ID: 19554920
[TBL] [Abstract][Full Text] [Related]
8. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
Balamuthusamy S; Srinivasan L; Verma M; Adigopula S; Jalandhara N; Hathiwala S; Smith E
Am Heart J; 2008 May; 155(5):791-805. PubMed ID: 18440325
[TBL] [Abstract][Full Text] [Related]
9. Anaemia and renal dysfunction in chronic heart failure.
van der Meer P; van Veldhuisen DJ
Heart; 2009 Nov; 95(21):1808-12. PubMed ID: 19828825
[No Abstract] [Full Text] [Related]
10. [Fosinopril in the treatment of cardiorenal syndrome in chronic cardiac failure].
Tereshchenko SN; Zhirov IV
Ter Arkh; 2009; 81(5):84-8. PubMed ID: 19537594
[TBL] [Abstract][Full Text] [Related]
11. [The cardiorenal anemia syndrome and treatment with EPO].
Karle H; Hansen NE
Ugeskr Laeger; 2006 Aug; 168(33):2686. PubMed ID: 16953546
[No Abstract] [Full Text] [Related]
12. [Combined cardio-renal failure: a key factor in heart failure progression and therapy].
Caramelo C; Gil P
Rev Esp Cardiol; 2006 Feb; 59(2):87-90. PubMed ID: 16540027
[No Abstract] [Full Text] [Related]
13. Mediators of anemia in chronic heart failure.
Le Jemtel TH; Arain S
Heart Fail Clin; 2010 Jul; 6(3):289-93. PubMed ID: 20630403
[TBL] [Abstract][Full Text] [Related]
14. Cardiorenal risk: an important clinical intersection.
McCullough PA
Rev Cardiovasc Med; 2002; 3(2):71-6. PubMed ID: 12447150
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors.
Jie KE; Verhaar MC; Cramer MJ; van der Putten K; Gaillard CA; Doevendans PA; Koomans HA; Joles JA; Braam B
Am J Physiol Renal Physiol; 2006 Nov; 291(5):F932-44. PubMed ID: 16885153
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic strategies for heart failure in cardiorenal syndromes.
House AA; Haapio M; Lassus J; Bellomo R; Ronco C
Am J Kidney Dis; 2010 Oct; 56(4):759-73. PubMed ID: 20557988
[TBL] [Abstract][Full Text] [Related]
18. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?
Schrier RW
J Am Coll Cardiol; 2006 Jan; 47(1):1-8. PubMed ID: 16386657
[TBL] [Abstract][Full Text] [Related]
19. The clinical challenge of cardiorenal syndrome.
Shlipak MG; Massie BM
Circulation; 2004 Sep; 110(12):1514-7. PubMed ID: 15381655
[No Abstract] [Full Text] [Related]
20. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
Onuigbo MA; Onuigbo NT
QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
